Neurology Associates' Dr. Andrea An discusses the significance of the FDA's new approval for the Alzheimer's drug Lequembi.

For most people, the worst of COVID-19 has passed. But did you know that long COVID continues to impact about 16 million U.S. adults? And...

Recent statistics indicate that almost one-quarter of U.S. adults felt depressed within the last two weeks. That’s a significant number...

Given the conditions and symptoms outlined in the previous blogs in our series, “FAQs About Neurology and Neurologists,” knowing how to...

Researchers at Oregon Health & Science University have made a big discovery regarding Parkinson's.

Neurology Associates Neuroscience Center looks at the side effects of lecanemab, the newly FDA-approved drug for Alzheimer's.

Neurology Associates brought on six new experts -- two neurologists, two physician assistants, and two nurse practitioners -- in 2022.